Boston University, the Division of Materials Science & Engineering and the Center for Nanoscience and Nanobiotechnology will be hosting BU MATERIALS DAY 2015: Nanomaterials in Medicine: Improving Healthcare Through SMALL Innovations on September 25, 2015 in the Photonics Center.
All are welcome to attend! Registration is required.
Registration deadline is September 14, 2015.
There will be a poster session, but space for posters is limited, so please register early.
The impact of nanomaterials on the practice of medicine far exceeds its dimensions. Nanomaterials have unique physicochemical, electromagnetic, and pharmacological properties that enable innovative strategies for diagnosing and treating disease. Targeted imaging probes engineered with nanomaterials allows clinicians and scientists to detect anatomical and pathological abnormalities indicative of disease with biomedical imaging systems. Nanomaterials have also been co-opted for chemical modification or packaging of therapeutic agents, augmenting their bio-distribution, increasing their specificity, and enhancing their efficacy while minimizing off-target adverse effect. In this symposium, leading scientists will present on medical breakthroughs that have been made possible through novel formulations and constructs of nanomaterials.
Program and Abstracts
Vladimir Torchilin, Ph.D.
Distinguished Professor, Pharmaceutical Sciences
Director, Center for Pharmaceutical Biotechnology and Nanomedicine
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
Heather Maynard, Ph.D.
University of California, Los Angeles
Professor, Chemistry and Biochemistry
Director of the Chemistry Biology Interface Training Program
Associate Director of Technology and Development for the California NanoSystems Institute
Bio-inspired and degradable nanomaterials for delivery of proteins
Mark Grinstaff, Ph.D.
Professor, Chemistry, Biomedical Engineering, and Materials Science & Engineering
Director, Center for Nanoscience and Nanotechnology
Title of talk: TBA
Patrick Stayton, Ph.D.
University of Washington
Washington Research Foundation Professor, Bioengineering
Director, Institute for Molecular Engineering and Sciences
Director, Center for Intracellular Delivery of Biologics
Intracellular Delivery of Biologic Drugs
Anna Moore, Ph.D.
Massachusetts General Hospital/Harvard Medical School
Director, Molecular Imaging Laboratory at the
MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging,
Image-guided RNA-based cancer therapies
Niren Murthy, Ph.D.
University of California, Berkeley
New strategies for imaging infectious diseases and oxidative stress
Andrew Tsourkas, Ph.D.
University of Pennsylvania
Associate Professor, Bioengineering
Associate Director, Program in Targeted Therapeutics, Institute of Translational Medicine and Therapeutics
Engineering targeted nanoparticles for molecular imaging and therapeutic applications
Allison Dennis, Ph.D.
Assistant Professor, Biomedical Engineering and Materials Science & Engineering
Engineering Thick-shelled Quantum Dot Heterostructures for Biosensing and Bioimaging
Associate Professor ME, MSE